Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1985]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
New AI tool accurately detects six different cancer types on whole-body PET/CT scans
New AI tool accurately detects six different cancer types on whole-body PET/CT scans
Advancing cancer tracking: DiFC detects rare cells noninvasively
Advancing cancer tracking: DiFC detects rare cells noninvasively
ASCO 2024: New ‘Armoured’ CAR produces significant responses in patients whose cancers don't respond to current CAR T cell therapies
ASCO 2024: New ‘Armoured’ CAR produces significant responses in patients whose cancers don't respond to current...
ASCO 2024: CAR T-cell therapy shows promise in patients with central nervous system lymphoma
ASCO 2024: CAR T-cell therapy shows promise in patients with central nervous system lymphoma
ASCO 2024: Dual immunotherapy treatment before surgery, rather than after, improves outcomes in melanoma patients
ASCO 2024: Dual immunotherapy treatment before surgery, rather than after, improves outcomes in melanoma patients
ASCO 2024: Adding belantamab mafodotin to multiple myeloma treatment combinations slows disease progression or death
ASCO 2024: Adding belantamab mafodotin to multiple myeloma treatment combinations slows disease progression or...
ASCO 2024: Shorter durations of venetoclax yields similar response rates in AML
ASCO 2024: Shorter durations of venetoclax yields similar response rates in AML
ASCO 2024: Novel CAR T cell therapy obe-cel yields strong remission rates in adults with relapsed or refractory B-ALL
ASCO 2024: Novel CAR T cell therapy obe-cel yields strong remission rates in adults with relapsed or refractory B...
ASCO 2024: Novel therapy combination more effective at treating Hodgkin lymphoma than established treatment
ASCO 2024: Novel therapy combination more effective at treating Hodgkin lymphoma than established treatment
ASCO 2024: Asciminib may be safer, more effective treatment option for patients with newly diagnosed chronic myeloid leukaemia
ASCO 2024: Asciminib may be safer, more effective treatment option for patients with newly diagnosed chronic...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation